(Q37691808)

22 August 2017

Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients (English)

1 reference

ORCID Public Data File 2021

22 August 2017

1 reference

urinary tract infection

1 reference

1 reference

author name string

P Rattanaumpawan

1

1 reference

22 August 2017

P Tolomeo

2

1 reference

22 August 2017

W B Bilker

3

1 reference

22 August 2017

N O Fishman

4

1 reference

22 August 2017

E Lautenbach

5

1 reference

22 August 2017

9 August 2010

1 reference

Epidemiology and Infection

22 August 2017

1 reference

22 August 2017

139

1 reference

22 August 2017

6

1 reference

22 August 2017

955-961

1 reference

Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Fluoroquinolone prescribing in the United States: 1995 to 2002.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

CDC definitions for nosocomial infections, 1988

23 August 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

14 September 2017

https://api.crossref.org/works/10.1017%2FS095026881000186X

inferred from DOI database lookup

7 January 2021

based on heuristic

Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Epidemiology of quinolone resistance: Europe and North and South America.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Mutational resistance to 4-quinolone antibacterial agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

The categorization of prior antibiotic use: impact on the identification of risk factors for drug resistance in case control studies

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3979467

Bacteremia in Previously Hospitalized Patients: Prolonged Effect From Previous Hospitalization and Risk Factors for Antimicrobial-Resistant Bacterial Infections

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1017%2FS095026881000186X

The sensitivity of gram-negative and gram-positive bacteria to ofloxacin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20696087

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20696087

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1017/S095026881000186X

1 reference

22 August 2017

1 reference

22 August 2017

1 reference